Apple and Masimo's patent and trade secret dispute has intensified through lawsuits as Apple defends its innovations and ...

Buying $1000 In MASI: If an investor had bought $1000 of MASI stock 10 years ago, it would be worth $5,655.84 today based on a price of $144.22 for MASI at the time of writing.

The consensus rating for Masimo is Buy, based on 2 analyst ratings. With an average one-year price target of $167.5, there's a potential 16.14% upside.

Beyond analysts' top -and-bottom-line estimates for Masimo (MASI), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ...

The global non-invasive respiratory monitoring market is poised for substantial growth, projected to increase from an estimated valuation of USD 8.4 Billion in 2023 to USD 15.0 Billion by 2033, at a ...

The man who acquired Sound United and founded US Health Company Masimo has been sacked by his own board, and to top that that ...

We recently published a list of 8 Most Promising Medical Stocks According to Hedge Funds. In this article, we are going to ...

The healthcare sector depends on medical technology advancements, particularly devices used in disease prevention, diagnosis, ...

A variety of medical device innovations and diagnostics have been named by Time as some of the best inventions of 2024.

In the latest lawsuit, Apple was awarded $250 in damages – the statutory minimum, which was what the company sought in its ...

A US Court hearing the case of Apple Vs Masimo appear to have given Apple a two finger salute by awarding them US$250, the ...

These are independent reviews of the products mentioned, but TIME receives a commission when purchases are made through ...